Genenta Science S.p.A. (NASDAQ:GNTA) Sees Large Increase in Short Interest

Posted by Stephan Jacobs on Jul 1st, 2024

Genenta Science S.p.A. (NASDAQ:GNTA – Get Free Report) was the recipient of a significant growth in short interest in the month of June. As of June 15th, there was short interest totalling 5,000 shares, a growth of 47.1% from the May 31st total of 3,400 shares. Based on an average daily trading volume, of 4,300 shares, the short-interest ratio is currently 1.2 days.

Analyst Upgrades and Downgrades

Separately, HC Wainwright reaffirmed a “buy” rating and issued a $25.00 target price on shares of Genenta Science in a research report on Monday, May 13th.

View Our Latest Analysis on Genenta Science

Genenta Science Price Performance

NASDAQ GNTA traded up $0.02 during trading hours on Monday, hitting $3.12. The company had a trading volume of 4,424 shares, compared to its average volume of 4,682. Genenta Science has a fifty-two week low of $2.20 and a fifty-two week high of $6.39. The business has a fifty day simple moving average of $3.25 and a 200-day simple moving average of $3.82.

Genenta Science Company Profile

(Get Free Report)

Genenta Science S.p.A., a clinical-stage biotechnology company, engages in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy. Its lead product candidate is Temferon, which is in Phase 1/2a clinical trials for use in the treatment of glioblastoma multiforme in patients with unmethylated MGMT gene promoter.